Salix partners with Colorectal Cancer Alliance on community screening program

Bausch Health Companies and its gastroenterology business, Salix Pharmaceuticals, announced a partnership with the Colorectal Cancer Alliance to increase awareness and access to preventative colorectal screenings in medically underserved communities. This May, the Alliance is launching a colorectal cancer screening and prevention initiative in Philadelphia with a focus on the communities facing the greatest disparities in health outcomes. In support of the Alliance’s efforts to improve access to these screenings, Salix will donate its prescription bowel preparation product to individuals who require a colonoscopy. Colonoscopies are a critical tool in the early detection of colorectal cancer. Research shows colorectal cancer can have a 90% survival rate if caught early.